Soft robotic devices for cardiovascular medicine

Nat Rev Cardiol. 2026 Apr 17. doi: 10.1038/s41569-026-01287-7. Online ahead of print.ABSTRACTConventional, rigid simulators and therapeutic devices for cardiovascular disease have several fundamental limitations, such as poor biomimetic fidelity, substantial surgical invasiveness and mismatch at the

X Xing-Yu Ji

Dysfunction of the episodic memory network in the Alzheimer's disease cascade

Nat Commun. 2026 Apr 17;17(1):3578. doi: 10.1038/s41467-026-71831-z.ABSTRACTAlzheimer's disease (AD) is a major cause of dementia and cognitive decline. Here, we assessed how episodic memory (EM) network dysfunction, a hallmark of AD, is related to the longitudinal progression of AD biomarkers, neur

R René Lattmann

Transcatheter Intra-Arterial Delivery of a Platelet-Derived Extracellular Vesicle-Enriched Preparation for Attenuating Skeletal Muscle Ischaemia-Reperfusion Injury in a Rodent Forelimb Model

J Extracell Vesicles. 2026 Apr;15(4):e70247. doi: 10.1002/jev2.70247.ABSTRACTExtracellular vesicles (EVs) are non-replicating, lipid membrane-bound nanoparticles released by most eukaryotic cells into the extracellular space. When derived from platelets, a subset of EVs can exhibit remarkable anti-i

O Omar A Selim

Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis

Clin Cardiol. 2026 Apr;49(4):e70308. doi: 10.1002/clc.70308.ABSTRACTBACKGROUND: Atrial fibrillation (AF) is a major cause of thromboembolic events, including ischemic stroke and transient ischemic attack (TIA). While Vitamin K antagonists (VKAs) have long been used for stroke prevention, Direct Oral

A Anam Nasir